Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SOL Global Investments Corp C.SOL

Alternate Symbol(s):  SOLCF

Healthcare Biotechnology
SOL Global Investments Corp. is a Canada-based diversified international investment and private equity holding company, which is engaged in investing in small and mid-cap sectors. The Company’s investments range from minority positions to strategic holdings with active advisory mandates with an objective of providing shareholders with a long-term return through capital appreciation, dividends... see more

Recent & Breaking News (CSE:SOL)

Scythian Biosciences Announces Name Change to SOL Global Investments Corp.

GlobeNewswire October 25, 2018

Scythian Biosciences Makes Strategic Investment in Verano™ Holdings with $188 Million USD Transaction

GlobeNewswire October 23, 2018

Verano™ Holdings Launched to Consolidate National Cannabis Assets with $120 Million Financing and Acquisition of Florida Licenses

GlobeNewswire October 23, 2018

Scythian Biosciences Applauds the UK Government’s Decision to Legalize Medical Cannabis

GlobeNewswire October 12, 2018

Scythian Biosciences Announces Major Milestone in U.S. Expansion

GlobeNewswire October 11, 2018

Scythian Biosciences Appoints Brady Cobb as CEO

GlobeNewswire October 3, 2018

Scythian Biosciences Announces Intention to Commence Normal Course Issuer Bid to Repurchase up to 5% of its Common Shares

GlobeNewswire October 1, 2018

Scythian Biosciences Appoints Peter Liabotis as CFO

GlobeNewswire September 28, 2018

IIROC Trade Resumption - SCYB

Canada NewsWire September 27, 2018

Scythian Biosciences Closes Strategic Sale of Latin American and Caribbean Assets

GlobeNewswire September 27, 2018

IIROC Trading Halt - SCYB

Canada NewsWire September 27, 2018

Scythian Biosciences Closes Acquisition of MMJ International Investments Inc.

GlobeNewswire September 21, 2018

Scythian Biosciences Announces Successful Results of Special Meeting of Shareholders

GlobeNewswire September 17, 2018

Scythian Biosciences Announces Execution of Share Purchase Agreement with MMJ International Investments Inc., owner of Argentina-based ABP S.A.

GlobeNewswire September 14, 2018

Scythian Biosciences Closes Acquisition of Marigold Projects Jamaica

GlobeNewswire September 13, 2018

Scythian Biosciences Corp. Announces Andy DeFrancesco as a New Director

GlobeNewswire September 4, 2018

Scythian Biosciences Closes Acquisition of MMJ Colombia Partners

GlobeNewswire August 27, 2018

Scythian Biosciences Shifts Focus Exclusively to The United States as National Acceptance of Medical Cannabis Surges

GlobeNewswire August 23, 2018

CSE New Listing - Scythian Biosciences Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Newsfile August 16, 2018

IIROC Trade Resumption - SCYB

Canada NewsWire August 15, 2018